Marine carotenoids and cardiovascular risk markers

Marine Drugs

Volumn 9, Issue 7, 2011, Pages 1166-1175

  Riccioni, Graziano ^a,b   D'Orazio, Nicolantonio ^b   Franceschelli, Sara ^b   Speranza, Lorenza ^b  

^a SAN CAMILLO DE LELLIS HOSPITAL   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Astaxanthin; Atherosclerosis; Cardiovascular disease; Free radicals; Fucoxantin; Marine carotenoids; Oxidized LDL

Indexed keywords

ANTIOXIDANT; ASTAXANTHIN; BETA CAROTENE; BIOLOGICAL MARKER; CAROTENOID; DOCOSAHEXAENOIC ACID; FREE RADICAL; FUCOXANTHIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ABSENCE OF SIDE EFFECTS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHRONIC INFLAMMATION; CLINICAL EFFECTIVENESS; DEGENERATIVE DISEASE; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DOSE RESPONSE; DRUG BIOAVAILABILITY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG METABOLISM; DRUG POTENCY; DRUG SAFETY; DYSLIPIDEMIA; GASTROINTESTINAL DISEASE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HYPERLIPIDEMIA; INFLAMMATORY DISEASE; LIVER DISEASE; METABOLIC SYNDROME X; NEOPLASM; NONHUMAN; OBESITY; OXIDATIVE STRESS; PREVENTION STUDY; REPERFUSION INJURY; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 79960787291     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md9071166     Document Type: Review

References (54)

1. World Health Organization. Diet, Nutrition, and the Prevention of Chronic Disease; WHO Technical Report Series 916; WHO: Geneva, Switzerland, 2003.
2. Neaton, J.; Wentworth, D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and difference by age for 316,099 white man. Multiple Risk Factor Intervention Trial Research Group. Arch. Intern. Med. 1992, 152, 56-64.
3. Riccioni, G. Carotenoids and cardiovascular disease. Curr. Atheroscler. Rep. 2009, 11, 434-439.
4. Riccioni, G.; D'Orazio, N.; Speranza, L.; Di Ilio, E.; Glade, M.; Bucciarelli, V.; Scotti, L.; Martini, F.; Pennelli, A.; Bucciarelli, T. Carotenoids and asymptomatic carotid atherosclerosis. J. Biol. Regul. Homeost. Agents 2010, 24, 447-452.
5. Gori, T.; Nzel, T.M. Oxidative stress and endothelial dysfunction: Therapeutic implications. Ann. Med. 2011, 43, 259-272.
6. Lee, S.; Park, Y.; Zuidema, M.Y.; Hannink, M.; Zhang, C. Effects of interventions on oxidative stress and inflammation of cardiovascular diseases. World J. Cardiol. 2011, 3, 18-24.
7. Gao, L.; Mann, G.E. Vascular NAD(P)H oxidase activation in diabetes: A double-edged sword in redox signalling. Cardiovasc. Res. 2009, 82, 9-20.
8. Rasmussen, H.H.; Hamilton, E.J.; Liu, C.C.; Figtree, G.A. Reversible oxidative modification: Implications for cardiovascular physiology and pathophysiology. Trends Cardiovasc. Med. 2010, 20, 85-90.
9. Yeh, C.T.; Ching, L.C.; Yen, G.C. Inducing gene expression of cardiac antioxidant enzymes by dietary phenolic acids in rats. J. Nutr. Biochem. 2009, 20, 163-171.
10. Khansari, N.; Shakiba, Y.; Mahmoudi, M. Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat. Inflamm. Allergy Drug Discov. 2009, 3, 73-80.
11. Dietary Guidelines for Americans, 5th ed.; Home and Garden Bulletin no. 232; US Department of Agriculture, US Department of Health and Human Services: Washington, DC, USA, 2000. Available online: http://www.nal.usda.gov/fnic/dga (accessed on 13 March 2011).
12. Sies, H.; Stahl, W. Vitamins E and C, beta-carotene, and other carotenoids as antioxidants. Am. J. Clin. Nutr. 1995, 62, 1315-1321.
13. Lichtenstein, A.H. Nutrient supplements and cardiovascular disease: A heartbreaking story. J. Lipid Res. 2009, 50, 429-433.
14. Gaziano, J.M.; Manson, J.E.; Branch L.G.; Colditz, G.A.; Willett, W.C.; Buring, J.E. A prospective study of consumption of carotenoids in fruits and vegetables and decreased cardiovascular mortality in the elderly. Ann. Epidemiol. 1995, 5, 255-260.
15. Jackson, H.; Braun, C.L.; Ernst, H. The chemistry of novel xanthophyll carotenoids. Am. J. Cardiol. 2008, 101, 50-57.
16. Miyashita, K. Function of marine carotenoids. Forum Nutr. 2009, 61, 136-146.
17. Paterson, E.; Gordon, M.H.; Niwat, C.; George, T.W.; Parr, L.; Waroonphan, S.; Lovegrove, J.A. Supplementation with fruit and vegetable soups and beverages increas plasma carotenoid concentrations but does not alter marker of oxidative stress or cardiovascular risk factors. J. Nutr. 2006, 136, 2849-2855. (Pubitemid 44771785)
18. Yuan, J.P.; Peng, J.; Yin, K.; Wang, J.H. Potential health-promoting effects of astaxanthin: A high-value carotenoid mostly from microalgae. Mol. Nutr. Food Res. 2011, 55, 150-165.
19. Pashkow, F.J.; Watumull, D.G.; Campbell, C.L. Astaxanthin: A novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am. J. Cardiol. 2008, 101, 58-68.
20. Ernst, H. Recent advances in industrial carotenoid synthesis. Pure Appl. Chem. 2002, 74, 2213-2226.
21. Montanti, J.; Nghiem, N.P.; Johnston, D.B. Production of astaxanthin from cellulosic biomass sugars by mutants of the yeast Phaffia rhodozyma. Appl. Biochem. Biotechnol. 2011, 164, 655-665.
22. Lockwood, S.F.; Gross, G.J. Disodium disuccinate astaxanthin (Cardax): Antioxidant and antiinflammatory cardioprotection. Cardiovasc. Drug Rev. 2005, 23, 199-216. (Pubitemid 41572013)
23. Gross, G.J.; Lockwood, S.F. Cardioprotection and myocardial salvage by a disodium disuccinate astaxanthin derivative (Cardax). Life Sci. 2004, 5, 215-224. (Pubitemid 38559076)
24. Gross, G.J.; Hazen, S.L.; Lockwood, S.F. Seven day oral supplementation with Cardax (disodium disuccinate astaxanthin) provides significant cardioprotection and reduces oxidative stress in rats. Mol. Cell Biochem. 2006, 283, 23-30.
25. Lauver, D.A.; Lockwood, S.F.; Lucchesi, B.R. Disodium disuccinate astaxanthin (Cardax) attenuates complement activation and reduces myocardial injury following ischemia/reperfusion. J. Pharmacol. Exp. Ther. 2005, 314, 686-692. (Pubitemid 41043850)
26. Iwamoto, T.; Hosoda, K.; Hirano, R. Inhibition of low-density lipoprotein oxidation by astaxanthin. J. Atheroscler. Thromb. 2000, 7, 216-222.
27. Rufer, C.E., Moeseneder, J.; Briviba, K. Bioavailability of astaxanthin stereoisomers from wild (Oncorhynchus spp.) and aquacultured (Salmo salar) salmon in healthy men: A randomised, double-blind study. Br. J. Nutr. 2008, 99, 1048-1054.
28. Coral-Hinostroza, G.N.; Ytrestoyl, T.; Ruyter, T.; Bjerkeng, B. Plasma appearance of unesterified astaxanthin geometrical E/Z and optical R/S isomers in men given single doses of a mixture of optical 3 and 3'R/S isomers of astaxanthin fatty acyl diesters. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2004, 139, 99-110. (Pubitemid 39535793)
29. Spiller, G.A.; Dewell, A. Safety of an astaxanthin-rich Haematococcus pluvialis algal extract: A randomized clinical trial. J. Med. Food 2003, 6, 51-56. (Pubitemid 36576614)
30. Karppi, J.; Rissanen, T.H.; Nyyssonen, K. Effects of astaxanthin supplementation on lipid peroxidation. Int. J. Vitam. Nutr. Res. 2007, 77, 3-11. (Pubitemid 46725262)
31. Cicero, A.F.; Rovati, L.C.; Setnikar, I. Eulipidemic effects of berberine administered alone or in combination with other natural cholesterol-lowering agents. A single-blind clinical investigation. Arzneimittel-Forschung 2007, 57, 26-30. (Pubitemid 46212985)
32. Yoshida, H.; Yanai, H.; Ito, K.; Tomono, Y.; Koikeda, T.; Tsukahara, H.; Tada, N. Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia. Atherosclerosis 2010, 209, 520-523.
33. Mercadante, A.Z.; Egeland, E.S. Carotenoids with a C40 skeleton. In Carotenoids-Handbook; Britton, G., Liaaen-Jensen, S., Pfander, H., Eds.; Birkhauser: Basel, Switzerland, 2004; p. 563.
34. Hu, T.; Liu, D.; Chen, Y.; Wu, J.; Wang, S. Antioxidant activity of sulfated polysaccharide fractions extracted from Undaria pinnitafida in vitro. Int. J. Biol. Macromol. 2010, 46, 193-198.
35. Nomura, T.; Kikuchi, M.; Kubodera, A.; Kawakami, Y. Proton-donative antioxidant activity of fucoxanthin with 1,1-diphenyl-2-picrylhydrazyl (DPPH). Biochem. Mol. Biol. Int. 1997, 42, 361-370. (Pubitemid 28297684)
36. Yan, X.; Chuda, Y.; Suzuki, M.; Nagata, T. Fucoxanthin as the major antioxidant in Hijikia fusiformis, a common edible seaweed. Biosci. Biotechnol. Biochem. 1999, 63, 605-607. (Pubitemid 129555518)
37. Woo, M.N.; Jeon, S.M.; Shin, Y.C.; Lee, M.K.; Kang, M.A.; Choi, M.S. Anti-obese property of fucoxanthin is partly mediated by altering lipid-regulating enzymes and uncoupling proteins of visceral adipose tissue in mice. Mol. Nutr. Food Res. 2009, 53, 1603-1611.
38. Ikeda, K.; Kitamura, A.; Machida, H.; Watanabe, M.; Negishi, H.; Hiraoka, J.; Nakano, T. Effect of Undaria pinnatifida (Wakame) on the development of cerebrovascular diseases in stroke-prone spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 2003, 30, 44-48. (Pubitemid 36232742)
39. Connor, W.E. Importance of n-3 fatty acids in health and disease. Am. J. Clin. Nutr. 2000, 71, 171-175.
40. Adan, Y.; Shibata, K.; Sato, M.; Ikeda, I.; Imaizumi, K. Effects of docosahexaenoic and eicosapentaenoic acid on lipid metabolism, eicosanoid production, platelet aggregation and atherosclerosis in hypercholesterolemic rats. Biosci. Biotechnol. Biochem. 1999, 63, 111-119. (Pubitemid 129555245)
41. Wang, S.; Wu, D.; Matthan, N.R.; Lamon-Fava, S.; Lecker, J.L.; Lichtenstein, A.H. Reduction in dietary omega-6 polyunsaturated fatty acids: Eicosapentaenoic acid plus docosahexaenoic acid ratio minimizes atherosclerotic lesion formation and inflammatory response in the LDL receptor null mouse. Atherosclerosis 2009, 204, 147-155.
42. Egert, S.; Kannenberg, F.; Somoza, V.; Erbersdobler, H.F.; Wahrburg, U. Dietary alpha-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans. J. Nutr. 2009, 139, 861-868.
43. Maeda, H.; Tsukui, T.; Sashima, T.; Hosokawa, M.; Miyashita, K. Seaweed carotenoid, fucoxanthin, as a multi-functional nutrient. Asia Pac. J. Clin. Nutr. 2008, 1, 196-199.
44. Maeda, H.; Hosokawa, M.; Sashima, T.; Miyashita, K. Dietary combination of fucoxanthin and fish oil attenuates the weight gain of white adipose tissue and decreases blood glucose in obese/diabetic KK-Ay mice. J. Agric. Food Chem. 2007, 55, 7701-7706. (Pubitemid 47522175)
45. Tsukui, T.; Konno, K.; Hosokawa, M.; Maeda, H.; Sashima, T.; Miyashita, K. Fucoxanthin and fucoxanthinol enhance the amount of docosahexaenoic acid in the liver of KKAy obese/diabetic mice. J. Agric. Food Chem. 2007, 55, 5025-5029. (Pubitemid 47056052)
46. Park, H.J.; Lee, M.K.; Park, Y.B.; Shin, Y.C.; Choi, M.S. Beneficial effects of Undaria pinnatifida ethanol extract on diet-induced-insulin resistance in C57BL/6J mice. Food Chem. Toxicol. 2010, 13, 357-363.
47. Hosokawa, M.; Miyashita, T.; Nishikawa, S.; Emi, S.; Tsukui, T.; Beppu, F.; Okada, T.; Miyashita, K. Fucoxanthin regulates adipocytokine mRNA expression in white adipose tissue of diabetic/obese KK-Ay mice. Arch. Biochem. Biophys. 2010, 504, 17-25.
48. Abidov, M.; Ramazanov, Z.; Seifulla, R.; Grachev, S. The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat. Diabetes Obes. Metab. 2010, 12, 72-81.
49. Kim, K.N.; Heo, S.J.; Kang, S.M.; Ahn, G.; Jeon, Y.J. Fucoxanthin induces apoptosis in human leukemia HL-60 cells through a ROS-mediated Bcl-xL pathway. Toxicol. Vitro 2010, 24, 1648-1654.
50. Jeon, S.M.; Kim, H.J.; Woo, M.N.; Lee, M.K.; Shin, Y.C.; Park, Y.B.; Choi, M.S. Fucoxanthin-rich seaweed extract suppresses body weight gain and improves lipid metabolism in high-fat-fed C57BL/6J mice. Biotechnol. J. 2010, 5, 961-969.
51. Shiratori, K.; Okgami, K.; Ilieva, I.; Jin, X.H.; Koyama, Y.; Miyashita, K.; Yoshida, K.; Kase, S.; Ohno, S. Effects of fucoxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Exp. Eye Res. 2005, 81, 422-428. (Pubitemid 41356505)
52. Granger, D.N.; Rodrigues, S.F.; Yildirim, A.; Senchenkova, E.Y. Microvascular responses to cardiovascular risk factors. Microcirculation 2010, 17, 192-205.
53. Pashkow, F.J.; Watumull, D.G.; Campbell, C.L. Astaxanthin: A novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am. J. Cardiol. 2008, 101, 58-68.
54. Fassett, R.G.; Healy, H.; Driver, R.; Robertson, I.K.; Geraghty, D.P.; Sharman, J.E.; Coombes, J.S. Astaxanthin vs. placebo on arterial stiffness, oxidative stress andinflammation in renal transplant patients (Xanthin): A randomised controlledtrial. BMC Nephrol. 2008, 18, 9-17.